文献速递呼吸道感染呼吸危重症与机械通气

肺移植后急性呼吸衰竭:肺炎与移植物功能障碍的对比

Pneumonia versus graft dysfunction as the cause of acute respiratory failure after lung transplant: a 4-year multicentre prospective study in 153 adults requiring intensive care admission.
PubMed 文献 · Eur Respir J · 2019-10-01

这项西班牙五中心前瞻性队列研究纳入2012至2016年间肺移植后再次入住ICU的成人受者,共153人、174次ICU再入院。急性呼吸衰竭是主要再入院原因,肺炎是最主要病因且为ICU死亡的独立预测因素,RAS患者应接受姑息治疗而非ICU收治。

要点

  • 急性呼吸衰竭是肺移植后ICU再入院的主因,病死率高
  • 肺炎是ICU再入院最主要病因,也是ICU死亡的独立预测因素
  • RAS患者应接受姑息治疗,而非收入ICU

核心结论

  • 急性呼吸衰竭是肺移植受者ICU再入院的主要情形,并与高病死率相关。
  • 肺炎是死亡主因,且为ICU死亡的独立预测因素。
  • RAS患者应接受姑息治疗,而非收入ICU。

研究设计与样本

  • 西班牙五中心前瞻性队列研究。
  • 纳入2012至2016年肺移植后离开ICU又再次入住ICU的全部成人受者,随访至出院或死亡。
  • 153例肺移植受者共发生174次ICU再入院,距移植中位时间6(2-25)个月。

主要发现

  • 慢性移植物功能障碍见于39例(25.5%)受者,其中13例为限制性移植物综合征(RAS),全部死亡。
  • 急性呼吸衰竭需ICU再入院110例(71.9%)。
  • 移植物排斥仅引起12例(10.8%)再入院(其中急性6例,5.4%);肺炎56例(36.6%)为主要原因(50例因急性呼吸衰竭、6例因休克入院),以铜绿假单胞菌为主(50%为多重耐药)。
  • ICU死亡55例(35.9%),住院死亡69例(45.1%)。
  • 多因素分析中,BOS 2期(aOR 7.2,95%CI 1.0-65.7)、BOS 3期(aOR 13.7,95%CI 2.5-95.3)、RAS(aOR >50)及ICU再入院时肺炎(aOR 2.5,95%CI 1.0-7.1)为ICU死亡的独立预测因素。

关键数值与推荐

  • BOS 2期与ICU死亡相关:aOR 7.2(95%CI 1.0-65.7)。
  • BOS 3期与ICU死亡相关:aOR 13.7(95%CI 2.5-95.3)。
  • RAS与ICU死亡相关:aOR >50。
  • ICU再入院时肺炎与ICU死亡相关:aOR 2.5(95%CI 1.0-7.1)。

临床怎么用

  • 肺移植受者出现急性呼吸衰竭再入院时,应优先评估感染尤其是肺炎。
  • 对BOS 2/3期或RAS患者应提前沟通预后与照护目标。
  • RAS患者建议姑息治疗而非ICU收治。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We aimed to assess the main causes of intensive care unit (ICU) readmissions in lung transplant adults and to identify independent predictors of ICU mortality (primary end-point).This Spanish five-centre prospective cohort study enrolled all lung transplant adults with ICU readmissions after post-transplant ICU discharge between 2012 and 2016. Patients were followed until hospital discharge or death.153 lung transplant recipients presented 174 ICU readmissions at a median (interquartile range) of 6 (2-25) months post-transplant. Chronic lung allograft dysfunction was reported in 39 (25.5%) recipients, 13 of whom (all exitus) had restrictive allograft syndrome (RAS). Acute respiratory failure (ARF) (110 (71.9%)) was the main condition requiring ICU readmission. Graft rejection (six (5.4%) acute) caused only 12 (10.8%) readmissions whereas pneumonia (56 (36.6%)) was the main cause (50 admitted for ARF and six for shock), with Pseudomonas aeruginosa (50% multidrug resistant) being the predominant pathogen. 55 (35.9%) and 69 (45.1%) recipients died in the ICU and the hospital, respectively. Bronchiolitis obliterans syndrome (BOS) stage 2 (adjusted OR (aOR) 7.2 (95% CI 1.0-65.7)), BOS stage 3 (aOR 13.7 (95% CI 2.5-95.3)), RAS (aOR >50) and pneumonia at ICU readmission (aOR 2.5 (95% CI 1.0-7.1)) were identified in multivariate analyses as independent predictors of ICU mortality. Only eight (5.2%) patients had positive donor-specific antibodies prior to ICU readmission and this variable did not affect the model.ARF was the main condition requiring ICU readmission in lung transplant recipients and was associated with high mortality. Pneumonia was the main cause of death and was also an independent predictor. RAS should receive palliative care rather than ICU admission.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Mazo C, Pont T, Ballesteros MA, et al. Pneumonia versus graft dysfunction as the cause of acute respiratory failure after lung transplant: a 4-year multicentre prospective study in 153 adults requiring intensive care admission. Eur Respir J. 2019. PMID: 31346003. doi:10.1183/13993003.01512-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。